Back to search

Article

Predicting neoadjuvant treatment response in triple-negative breast cancer using machine learning

2023-04-20

Abstract excerpt

<h4>Background</h4> Neoadjuvant chemotherapy (NAC) is the standard treatment for early-stage triple negative breast cancer (TNBC). The primary endpoint of NAC is a pathological complete response (pCR). NAC results in pCR in only 30%–40% of TNBC patients. Tumor-infiltrating lymphocytes (TILs), Ki67 and phosphohistone H3 (pH3) are a few known biomarkers to predict NAC response. Currently, systematic evaluation of t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fecc1bf2-7d34-59cf-96cb-53ad5f8ccb2c
DOI
10.1101/2023.04.17.536459
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting neoadjuvant treatment response in triple-negative breast cancer using machine learningDOI 10.1101/2023.04.17.536459
Select a neighboring publication to make it the new centre.